Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
8.57
+0.21 (2.51%)
Nov 21, 2024, 11:24 AM EST - Market open
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $526.51 million as of November 21, 2024. Its market cap has increased by 219.35% in one year.
Market Cap
526.51M
Enterprise Value
315.12M
1-Year Change
219.35%
Ranking
Category
Stock Price
$8.57
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $526.51M, a decrease of -37.71%. That is a compound annual growth rate of -12.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 510.53M | 80.50% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProKidney | 524.99M |
| Talkspace | 521.97M |
| Fulgent Genetics | 519.98M |
| Opthea | 517.94M |
| SI-BONE | 516.68M |
| Pharming Group | 509.63M |
| Savara | 504.56M |
| Community Health Systems | 504.42M |